Hypertensive Disorders and ABO Incompatibility in Pregnancy

Eclampsia

Eclampsia is the most severe progression of these disorders, characterized by the onset of grand mal seizures in a patient who already has preeclampsia.

Superimposed Preeclampsia/Eclampsia

This occurs when a patient with pre-existing chronic hypertension begins to show the signs and symptoms of preeclampsia or develops eclamptic seizures.

Exam Tip: Always distinguish between Preeclampsia and Eclampsia. If the question mentions "seizures" or "convulsions," the diagnosis is Eclampsia.

HELLP Syndrome and Severe Complications

Severe preeclampsia can progress to HELLP Syndrome, an acronym for Hemolysis, Elevated Liver enzymes, and Low Low Platelets. Other dangerous complications include acute tubular necrosis (kidney failure), increased intraocular pressure, and central nervous system (CNS) changes.

Nursing Management of Hypertension

Nursing care for hypertensive disorders focuses on rigorous assessment, timely treatment, and patient education.

Key Assessments:

• Monitoring blood pressure and vital signs.
• Checking for proteinuria via urine tests.
• Performing a 24-hour urine creatinine clearance to assess kidney function.
• Continuous monitoring of laboratory values (AST/ALT, platelets, and creatinine).

Pharmacological Interventions:

• Anti-hypertensives: Medications such as nifedipine are used to manage blood pressure.
• Magnesium Sulfate: This is administered specifically as an anti-seizure medication to prevent the onset of eclampsia.

ABO Blood Incompatibility

ABO incompatibility is an immunological issue that arises when the mother's blood type is incompatible with the fetus's blood type. This most commonly occurs when a mother has Type O blood.

Pathophysiology and Hemolysis

Mothers with Type O blood possess naturally occurring anti-A and anti-B antibodies. These antibodies are capable of crossing the placenta to enter the fetal circulation. If the fetus has Type A or Type B blood, these maternal antibodies will attack the fetal red blood cells, leading to hemolysis (the destruction of red blood cells).

Clinical Implications

The primary clinical concern for the infant is jaundice, caused by the high levels of bilirubin released during red blood cell breakdown. If hemolysis is severe and not closely monitored, it can lead to significant neurological problems or even death in the infant.

Diagnostic Tools: The Coombs Test

To manage and monitor this risk, healthcare providers use Coombs tests:

• Indirect Coombs Test: Performed on the mother's blood to screen for the presence of antibodies.
• Coombs Test (Direct): Performed on the baby's blood at birth to detect antibodies attached to the infant's red blood cells.